Novel medicine composition for treating hepatitis B virus and preparation method
A hepatitis B virus and new drug technology, applied in the field of new drug combination and preparation for the treatment of hepatitis B virus, can solve the problems of poor anti-liver and anti-viral activity, prone to nephrotoxicity, drug resistance and the like, and achieves protection of the liver and a simple preparation method. Convenient, fast-acting results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment I
[0045] Embodiment 1, a kind of preparation method of treating hepatitis B virus new drug combination of the present invention comprises the following steps:
[0046] S1. Micronize the bulk drug of the compound of formula I or its pharmaceutically acceptable salt to obtain micropowder A;
[0047] S2, uniformly mixing the filler and the disintegrant to obtain a mixture a;
[0048] S3 adding the binder into the wetting agent to obtain the mixture b;
[0049] S4. After the mixture a and the mixture b are mixed, the granules are granulated by wet method, and then the granules are sized and dried to obtain the granules B;
[0050] S5. Spray the micropowder A evenly on the particle B, and then dry to obtain the dry particle C;
[0051] S6. Add lubricant to dry granules C, mix evenly, and then compress to obtain bare chips;
[0052] S7. After adding the coating agent to the bare tablet, perform a coating process to obtain a tablet, thereby obtaining a tablet of the new drug combina...
Embodiment II
[0053] Embodiment II, a kind of preparation method for the treatment of hepatitis B virus drug combination of the present invention comprises the following steps:
[0054] (1) Micronize the crude drug of the compound of formula I or its pharmaceutically acceptable salt to obtain micropowder A, and micronize tenofovir disoproxil to obtain micropowder B;
[0055] (2) Mix the filler and the disintegrant uniformly to obtain mixture a, and add the adhesive to the wetting agent to obtain mixture b;
[0056] (3) After mixture a and mixture b are mixed, granulate by wet method, then granulate and dry to obtain granule B;
[0057] (4) Spray micropowder A evenly on particle B, and then dry to obtain dry particle C;
[0058] (5) Add a lubricant to the dry granule C and mix to obtain a mixture D, add micropowder B to the mixture D and mix evenly, and then press into tablets to obtain a bare chip;
[0059] (6) After adding the coating agent to the bare tablet, perform a coating process to ...
Embodiment 1
[0062] A new drug combination for the treatment of hepatitis B virus, consisting of 50% filler, 0.4% lubricant, 1% binder, 6% disintegrant, 4% coating agent, 25% wetting agent, 5% tenofo Viril dipivoxil, prepared into a new drug drug combination oral tablet whose specification is 0.5mg / tablet.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com